Wide Ranks

CDIOW

0.0300

Top Statistics
Market Cap 0.0000 Forward PE 0.0000 Revenue Growth 356.20 %
Current Ratio 5.69 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins -16295.55 %
Balance Sheet
Total Cash 1 M Total Cash Per Share 0.0550 Total Debt 870448
Total Debt To Equity 28.31 Current Ratio 5.69 Book Value Per Share 0.1440
All Measures
Message Board Id finmb_1671478040 Return On Equity -2.93 City Chicago
Uuid 4819eee8-b954-3e61-a186-b3ae3c37281a Previous Close 0.0371 Book Value 0.1440
Beta 4.68 Total Debt 870448 Volume 157
Price To Book 0.2083 Fifty Two Week Low 0.0300 Total Cash Per Share 0.0550
Total Revenue 39138 Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins -16295.55 % Net Income To Common -8772890 Trailing Peg Ratio None
Total Cash 1 M Revenue Per Share 0.0020 Trailing PE 0.0000
Regular Market Previous Close 0.0371 Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000
Open 0.0300 Free Cashflow -5918657 State IL
Dividend Yield 0.00 % Return On Assets -0.9795 Time Zone Short Name EST
Day Low 0.0300 Address1 311 West Superior Street Target High Price 0.0000
Price Hint 4 Website https://cardiodiagnosticsinc.com Forward Eps 0.0000
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 350.30 %
Is_sp_500 False Regular Market Day High 0.0300 Profit Margins 0.00 %
Debt To Equity 28.31 Fifty Two Week High 0.0300 Day High 0.0300
Regular Market Open 0.0300 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 356.20 % Operating Cashflow -5173726 Currency USD
Time Zone Full Name America/New_York Is_nasdaq_100 False Market Cap 0.0000
Zip 60654 Quote Type EQUITY Industry Biotechnology
Long Name Cardio Diagnostics Holdings, Inc. Regular Market Day Low 0.0300 Current Price 0.0300
Address2 Suite 444 Financial Currency USD Current Ratio 5.69
Gross Margins 100.00 % Industry Disp Biotechnology Country United States
Float Shares 20 M Forward PE 0.0000 Regular Market Volume 157
Ebitda -8215199 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.

It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.

Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.